.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
UBS
AstraZeneca
Teva
Johnson and Johnson
Cipla
Cantor Fitzgerald
Moodys
US Army
Medtronic

Generated: July 23, 2017

DrugPatentWatch Database Preview

Propantheline bromide - Generic Drug Details

« Back to Dashboard

What are the generic sources for propantheline bromide and what is the scope of propantheline bromide patent protection?

Propantheline bromide
is the generic ingredient in two branded drugs marketed by Mylan, West-ward Pharms Int, Sandoz, Tablicaps, Watson Labs, Shire, Impax Labs, Gd Searle Llc, Ascot, Par Pharm, Pvt Form, and Heather, and is included in thirteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for propantheline bromide. One supplier is listed for this compound.

Summary for Generic Name: propantheline bromide

Tradenames:2
Patents:1
Applicants:12
NDAs:13
Drug Master File Entries: see list7
Suppliers / Packagers: see list1
Bulk Api Vendors: see list36
Clinical Trials: see list273
Patent Applications: see list1,617
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:propantheline bromide at DailyMed

Pharmacology for Ingredient: propantheline bromide

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
PROPANTHELINE BROMIDE
propantheline bromide
TABLET;ORAL088377-001Dec 8, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Shire
PRO-BANTHINE
propantheline bromide
TABLET;ORAL008732-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Tablicaps
PROPANTHELINE BROMIDE
propantheline bromide
TABLET;ORAL084428-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
PROPANTHELINE BROMIDE
propantheline bromide
TABLET;ORAL080928-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Heather
PROPANTHELINE BROMIDE
propantheline bromide
TABLET;ORAL085780-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Harvard Business School
Moodys
Novartis
Accenture
Cantor Fitzgerald
Medtronic
AstraZeneca
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot